ATE477236T1 - ALPHA-AMINO ACID DERIVATIVES WITH ANTI-INFLAMMATORY EFFECT - Google Patents

ALPHA-AMINO ACID DERIVATIVES WITH ANTI-INFLAMMATORY EFFECT

Info

Publication number
ATE477236T1
ATE477236T1 AT05752620T AT05752620T ATE477236T1 AT E477236 T1 ATE477236 T1 AT E477236T1 AT 05752620 T AT05752620 T AT 05752620T AT 05752620 T AT05752620 T AT 05752620T AT E477236 T1 ATE477236 T1 AT E477236T1
Authority
AT
Austria
Prior art keywords
alpha
amino acid
acid derivatives
inflammatory effect
compounds
Prior art date
Application number
AT05752620T
Other languages
German (de)
Inventor
Massimo Pinori
Rocco Mazzaferro
Paolo Mascagni
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Application granted granted Critical
Publication of ATE477236T1 publication Critical patent/ATE477236T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/08—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Compounds of the formula: are described in which Z, Q, X, L, m and n assume the meanings stated in the description. The compounds (I) inhibit the production of TNF alpha and may thus be useful in the treatment of inflammation and pathological conditions involving overproduction of said cytokine. They furthermore exhibit significant inhibitory activity on the proliferation of tumour cells and may thus be used for the treatment and/or prevention of tumorous, neurodegenerative or autoimmune disorders.
AT05752620T 2004-07-05 2005-06-07 ALPHA-AMINO ACID DERIVATIVES WITH ANTI-INFLAMMATORY EFFECT ATE477236T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001347A ITMI20041347A1 (en) 2004-07-05 2004-07-05 ALPHA-AMINO ACID DERIVATIVES FOR ANTI-INFLAMMATORY ACTIVITIES
PCT/EP2005/052597 WO2006003068A2 (en) 2004-07-05 2005-06-07 Alpha-amino acid derivatives with antiinflammatory activity

Publications (1)

Publication Number Publication Date
ATE477236T1 true ATE477236T1 (en) 2010-08-15

Family

ID=35783213

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05752620T ATE477236T1 (en) 2004-07-05 2005-06-07 ALPHA-AMINO ACID DERIVATIVES WITH ANTI-INFLAMMATORY EFFECT

Country Status (12)

Country Link
US (1) US7635788B2 (en)
EP (1) EP1763507B1 (en)
JP (1) JP4769248B2 (en)
KR (1) KR101183154B1 (en)
CN (1) CN100540530C (en)
AT (1) ATE477236T1 (en)
BR (1) BRPI0512751A (en)
CA (1) CA2570307C (en)
DE (1) DE602005022868D1 (en)
ES (1) ES2350585T3 (en)
IT (1) ITMI20041347A1 (en)
WO (1) WO2006003068A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1396915B1 (en) * 2009-10-23 2012-12-20 Italfarmaco Spa DIETYL- [6- (4-HYDROXICARBAMYL-PHENYL-CARBAMYLOSSIMETHYL) -NAFTALEN-2-IL-METHYL] -AMMONIUM CHLORIDE AND OTHER DERIVATIVES OF N-HYDROXY-BENZAMID FOR THE USE IN THE TREATMENT OF HIV INFECTIONS.
US8217079B2 (en) 2010-03-26 2012-07-10 Italfarmaco Spa Method for treating Philadelphia-negative myeloproliferative syndromes
CN102898332B (en) * 2011-07-25 2015-05-06 中国医学科学院医药生物技术研究所 A kind of hydroxamic acid derivative, its pharmaceutical composition, preparation method and application
ITUB20155193A1 (en) 2015-11-03 2017-05-03 Italfarmaco Spa Physically and chemically stable oral Givinostat suspensions
IT201600074606A1 (en) 2016-07-18 2018-01-18 Italfarmaco Spa New benzo-N-hydroxy amide compounds having antitumor activity
WO2018054960A1 (en) 2016-09-21 2018-03-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting and treating resistance to chemotherapy in npm-alk(+) alcl
SG11202009438UA (en) 2018-04-18 2020-11-27 Constellation Pharmaceuticals Inc Modulators of methyl modifying enzymes, compositions and uses thereof
CN112262143A (en) 2018-05-21 2021-01-22 星座制药公司 Modulators of methyl-modified enzymes, compositions and uses thereof
PH12022550188A1 (en) 2019-07-24 2022-11-21 Constellation Pharmaceuticals Inc Crystalline forms of 7-chloro-2-(4-(3-methoxyazetidin-1-yl)cyclohexyl)-2,4-dimethyl-n-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide
CN114044801B (en) * 2021-12-02 2024-03-19 湖北省生物农药工程研究中心 A kind of tyrosine derivative and its preparation method and application

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496540A (en) 1982-12-30 1985-01-29 Biomeasure, Inc. Therapeutic compounds
JPH01146896A (en) * 1987-12-04 1989-06-08 Fuji Yakuhin Kogyo Kk Novel peptidylhydroxamic acid derivative
IT1283637B1 (en) * 1996-05-14 1998-04-23 Italfarmaco Spa COMPOUNDS WITH ANTI-INFLAMMATORY AND IMMUNOSOPPRESSIVE ACTIVITY
AUPO721997A0 (en) * 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds
WO2002026696A1 (en) * 2000-09-29 2002-04-04 Prolifix Limited Carbamic acid compounds comprising an amide linkage as hdac inhibitors
JPWO2003070691A1 (en) * 2002-02-21 2005-06-09 財団法人大阪産業振興機構 N-hydroxycarboxamide derivatives
PL1611088T3 (en) * 2003-04-07 2009-11-30 Pharmacyclics Inc Hydroxamates as therapeutic agents

Also Published As

Publication number Publication date
JP2008505158A (en) 2008-02-21
DE602005022868D1 (en) 2010-09-23
CA2570307C (en) 2012-04-17
EP1763507B1 (en) 2010-08-11
WO2006003068A2 (en) 2006-01-12
ITMI20041347A1 (en) 2004-10-05
CN1980886A (en) 2007-06-13
CA2570307A1 (en) 2006-01-12
KR20070038096A (en) 2007-04-09
EP1763507A2 (en) 2007-03-21
BRPI0512751A (en) 2008-04-08
WO2006003068A3 (en) 2006-06-01
JP4769248B2 (en) 2011-09-07
US20080076807A1 (en) 2008-03-27
CN100540530C (en) 2009-09-16
US7635788B2 (en) 2009-12-22
ES2350585T3 (en) 2011-01-25
KR101183154B1 (en) 2012-09-17

Similar Documents

Publication Publication Date Title
EA201501088A1 (en) Heteroaryl Compounds Used as E1 Inhibitors Activating Enzymes
NO20071534L (en) Treatment of inflammatory disorders and pain
MX2007004551A (en) Thiadiazole compounds and methods of use.
WO2005090333A8 (en) 3-‘4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
EA201500769A1 (en) E1 INHIBITORS ACTIVATING ENZYMES
GEP20104994B (en) Tetrahydroindolone and tetrahydroindazolone derivatives
ATE423087T1 (en) PROTEASOME INHIBITORS AND THEIR USE
MX392179B (en) NEW ANTI-INFLAMMATORY AGENTS.
TW200714590A (en) Heterocyclic inhibitors of MEK and methods of use thereof
EP4566675A3 (en) Heterocyclic compounds as immunomodulators
TW200738657A (en) Thiazole compounds and methods of use
DK1660507T3 (en) Proteasome inhibitors and methods for their use
NO20081349L (en) Pyrrolopyrimidine derivatives as Syk inhibitors
WO2007022225A3 (en) Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
DE602005022868D1 (en) ALPHA AMINO ACID DERIVATIVES WITH ANTI-INFLAMMATORY EFFECT
AU2003224923A1 (en) Heterocyclic amide derivatives as cytokine inhibitors
ATE346041T1 (en) N-HYDROXYFORMAMIDE DERIVATIVES
EA200401319A1 (en) NEW HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND THEIR USE IN MEDICINE
WO2006020358A3 (en) Novel biphenyl compounds and their use
EA200702094A1 (en) DERIVATIVES OF HETEROARYLMAN UTILS SUITABLE FOR THE INHIBITION OF CHK1
AU2003265924A1 (en) Benzimidazolones and their use as cytokine inhibitors
WO2007123777A3 (en) Inhibition of hif-1 activation for anti-tumor and anti-inflammatory responses
DE602005019893D1 (en) 2-ARYLCARBAMOYL INDOLE AS CYTOKINHEMMER
EA200701835A1 (en) AMIDIC DERIVATIVES AS THE LIGANDS OF IONIC CHANNELS, THEIR PHARMACEUTICAL COMPOSITIONS AND METHODS OF THEIR APPLICATION
UA84576C2 (en) Benzoimidazole compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties